← Open Payments lookup

RITA KAMMIEL: Open Payments

NPI 1427142736 · ABSECON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,602 in 97 payments from 15 companies in 2025. Trend: 2023 $2,510 · 2024 $2,006 · 2025 $1,602

Food & beverage: $1,602
CompanyPaymentsAmount
Alkermes, Inc.17$270
ABBVIE INC.13$226
Neurocrine BioSciences, Inc.11$163
Axsome Therapeutics, Inc.9$162
Lundbeck LLC9$139
Otsuka America Pharmaceutical, Inc.8$137
E.R. Squibb & Sons, L.L.C.7$115
Bausch Health US, LLC6$108
Vanda Pharmaceuticals Inc.4$69
Takeda Pharmaceuticals U.S.A., Inc.3$53

Products named: REXULTI, VRAYLAR, ARISTADA, INGREZZA, Auvelity, COBENFY, APLENZIN, FANAPT.

Industry payments across NJ — which companies pay providers there.